ZYMERON CORPORATION Federal Contracts — Government Award History
Total (All Time)$21M
Latest FY$4M
Primary AgencyDepartment of Defense
ZYMERON CORPORATION has received $21M in total federal contract awards
across 6 fiscal year(s). ▲ 1.3% vs FY2023 Peak year was FY2022 ($6M).
Primary awarding agency: Department of Defense.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2024 | $3.7M | 4건 | Department of Defense | |
| FY2023 | $3.6M | 3건 | Department of Defense | |
| FY2022 | $6.0M | 6건 | Department of Defense | |
| FY2021 | $4.5M | 10건 | Department of Health and Human Services | |
| FY2020 | $849,992 | 3건 | Department of Health and Human Services | |
| FY2019 | $2.1M | 3건 | Department of Health and Human Services |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2023-09-15 | Department of Defense | $3.0M | DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 |
| 2022-02-07 | Department of Defense | $3.0M | AWARD OF ZYMERON’S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR “DEVELOPMENT FOR A |
| 2024-09-20 | Department of Defense | $3.0M | DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATT |
| 2019-08-01 | Department of Health and Human Services | $1.5M | COMPLETE SBIR TOPIC 46 PHASE II TASKS |
| 2021-08-12 | Department of Health and Human Services | $1.3M | RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD. |
| 2022-07-11 | Department of Defense | $1.1M | AWARD OF ZYMERON’S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR “NOVEL ANTIBIOTICS |
| 2021-02-22 | Department of Defense | $1.1M | MEDICAL RESEARCH AND DEVELOPMENT ARMY STTR PH II PROPOSAL NO. A2-8349 TITLED LON |
| 2022-08-26 | Department of Defense | $989,815 | AUTOMATED PARTIAL OCCLUSION FOR TRUNCAL HEMORRHAGE CONTROL SBIR PHASE II AWARD |
| 2022-09-19 | Department of Health and Human Services | $400,000 | SBIR TOPIC 441. ZYMERON WILL DEVELOP USER-FRIENDLY TECHNOLOGIES AND DEVICES TO |
| 2023-08-07 | Department of Health and Human Services | $400,000 | RAPID POINT OF CARE TEST TO SCREEN HUMAN PAPILLOMAVIRUS IN LOW-RESOURCE SETTINGS |
| 2020-08-21 | Department of Health and Human Services | $300,000 | SBIR PHS 2020-1, TOPIC 084 ENTITLED “ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B |
| 2020-06-01 | Department of Health and Human Services | $300,000 | THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A NOVEL HIV VACCINE CO-DELIVERY SYS |
| 2021-07-01 | Department of Health and Human Services | $300,000 | THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN, SYNTHESIZE COMPOUNDS THAT BIND TO N |
| 2021-08-31 | Department of Health and Human Services | $300,000 | RAPID POINT OF CARE TESTS TO QUANTIFY HEPATITIS C VIRUS |
| 2021-07-01 | Department of Health and Human Services | $300,000 | THE CONTRACTOR SHALL DEVELOP A NOVEL NANOPARTICLE DELIVERY SYSTEM TO ELICIT POTE |
| 2021-09-03 | Department of Health and Human Services | $300,000 | ORODISPERSIBLE FILM OF SECOND LINE DRUG FOR PEDIATRIC TUBERCULOSIS TREATMENT. |
| 2022-07-01 | Department of Health and Human Services | $300,000 | POINT-OF-CARE (POC) DIAGNOSTICS FOR ANTIMICROBIAL RESISTANT (AMR) ENTERIC BACTER |
| 2019-09-09 | Department of Health and Human Services | $299,998 | SBIR PHASE 1 – TOPIC 394 – COMBINATORY TREATMENT MODALITIES UTILIZING RADIATION |
| 2021-07-01 | Department of Health and Human Services | $299,988 | THE CONTRACTOR SHALL PROPOSE NOVEL, LOW-COST, REAL-TIME POINT-OF-CARE (POC) ASSA |
| 2019-08-26 | Department of Health and Human Services | $299,920 | RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD |